What is a Quality Risk Assessment?
Quality Risk Assessment (QRA) is a cornerstone of modern pharmaceutical quality systems. In an industry where patient safety, regulatory compliance, and product integrity are non-negotiable, QRA provides a structured way to evaluate potential risks and implement controls before issues can affect product quality.
What is a Regulatory Gap Analysis?
In the pharmaceutical industry, compliance with evolving global regulations is critical to ensure patient safety, product quality, and uninterrupted market access. A Regulatory Gap Analysis is a systematic process used by pharma companies to identify discrepancies between current practices and regulatory requirements.
What Is a Regulatory Dossier?
In the pharmaceutical industry, the development and approval of medicinal products depend heavily on the quality and completeness of regulatory documentation. One of the most critical components of this documentation is the regulatory dossier.
What is a Certificate of Free Sale (CFS)?
In the pharmaceutical industry, international trade requires strict documentation to ensure product safety and compliance. One of the most important documents for exporting medicines and healthcare products is the Certificate of Free Sale (CFS).
What is Risk Management in Pharma?
Risk management in the pharmaceutical industry is a structured approach to identifying, assessing, and mitigating potential risks that may affect patient safety, product quality, or regulatory compliance.